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Systematic Review
Impact of Baseline Magnetic Resonance
Imaging on Neurologic, Functional, and
Safety Outcomes in Patients With Acute
Traumatic Spinal Cord Injury
Shekar Kurpad, MD, PhD1, Allan R. Martin, MD2,3, LindsayA.Tetreault,PhD3,
Dena J. Fischer, DDS, MSD, MS4, Andrea C. Skelly, PhD, MPH4,
David Mikulis, MD, FRCP(C)2,3, Adam Flanders, MD5, Bizhan Aarabi, MD6,
Thomas E. Mroz, MD7, Eve C. Tsai, MD, PhD, FRCSC8,9,
and Michael G. Fehlings, MD, PhD, FRCSC, FACS2,3
Abstract
Study Design: Systematic review.
Objective: To perform a systematic review to evaluate the utility of magnetic resonance imaging (MRI) in patients with acute
spinal cord injury (SCI).
Methods: An electronic search of Medline, EMBASE, the Cochrane Collaboration Library, and Google Scholar was conducted
for literature published through May 12, 2015, to answer key questions associated with the use of MRI in patients with acute SCI.
Results: The literature search yielded 796 potentially relevant citations, 8 of whichwere included in this review.One study usedMRI in a
protocol to decide on early surgical decompression. The MRI-protocol group showed improved outcomes; however, the quality of evi-
dencewasdeemedvery lowdue to selectionbias. Seven studies reportedMRIpredictorsof neurologicor functionaloutcomes.Therewas
moderate-quality evidence that longer intramedullary hemorrhage (2 studies) and low-quality evidence that smaller spinal canal diameter
at the locationofmaximal spinal cord compression and thepresenceof cord swelling are associatedwithpoorneurologic recovery.There
was moderate-quality evidence that clinical outcomes are not predicted by SCI lesion length and the presence of cord edema.
Conclusions: Certain MRI characteristics appear to be predictive of outcomes in acute SCI, including length of intramedullary
hemorrhage (moderate-quality evidence), canal diameter at maximal spinal cord compression (low-quality evidence), and spinal cord
swelling (low-quality evidence).Other imaging featureswere either inconsistently (presence of hemorrhage, maximal canal compromise,
and edema length) or not associated with outcomes. The paucity of literature highlights the need for well-designed prospective studies.
Keywords
spinal cord injury, magnetic resonance imaging, risk factors, neurologic outcomes, functional outcomes
Introduction
Imaging of the spine is an essential part of the early manage-
ment of the polytrauma patient.1 Most major trauma centers
have a variety of imaging modalities available for acute spinal
trauma. The choice of modality is determined by the need to
evaluate bony, ligamentous, soft tissue, and neural elements. In
the acute setting, imaging should provide a rapid and accurate
assessment of spinal stability, as well as guide clinical man-
agement. Current trauma protocols rely heavily on computed
tomography (CT),1 as it allows for efficient evaluation of the
head, body, and spine and identifies most injuries. High-quality
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imaging, however, cannot replace a good clinical examination,
but rather should supplement and confirm findings of the pri-
mary and secondary trauma survey.
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is not routinely used for
initial evaluation of the trauma patient. MRI is usually per-
formed after initial clinical and radiological (CT or X-rays)
evaluations, when further delineation of neural structures, such
as the spinal cord, nerve roots, or brachial plexus, is required
due to the presence of a neurological deficit or the suspicion of
a structural problem such as a ligamentous injury. Conven-
tional MRI, including T1- and T2-weighted imaging, provides
excellent views of the soft tissue and can readily identify fea-
tures of spinal cord compression such as intervertebral disc
herniation and epidural hematoma.1,2 Although CT is often
able to detect pre- and paravertebral soft tissue swelling, MRI
provides a more reliable detection of traumatic injury. Short-
tau inversion recovery sequences produce fat-suppressed
images that better delineate ligamentous injuries, which can
cause mechanical instability of the spinal column. T2-
weighted MRI is ideal for demonstrating intramedullary spinal
cord edema and hemorrhage; high signal intensity indicates
edema, while a focus of acute hemorrhage has low, heteroge-
neous signal intensity.3 Gradient echo (GRE) and susceptibility
weighted imaging (SWI) are highly sensitive for hemorrhage
and can also identify microhemorrhage consistent with cord
contusions.
The use of MRI for the initial evaluation of trauma patients
is limited largely by long scanning times. Although monitoring
is available in manyMRI suites, it is not advised to keep trauma
patients supine and flat for extended periods of time as a result
of pain and hemodynamic instability. Critically ill trauma
patients may also have concomitant head and chest injuries that
may result in increased intracranial pressure and decreased
ventilation during MRI acquisition.4 The use of a small number
of specific sequences with appropriate coils can reduce scan-
ning time. Current guidelines for the use of MRI in acute spine
trauma are based on limited available data.1
The primary goal of this study was to perform a systematic
review of the literature to (1) assess MRI features that may
affect clinical decision making and outcomes in patients with
acute SCI; (2) determine if baseline MRI characteristics can
predict neurologic, functional, and patient-reported outcomes;
(3) evaluate the safety of MRI in this population; and (4) char-
acterize the cost-effectiveness of MRI in acute SCI.
To accomplish this goal, we aimed to answer the following
key questions (KQ) in adult patients with acute traumatic SCI:
KQ1: How does MRI influence management strategy(ies),
such as surgical timing and approach, and/or neurologic,
functional, patient-reported, and safety outcomes?
KQ2: Do spinal cord lesion characteristics, pattern, and
length identified on baseline MRI predict neurologic, func-
tional, patient-reported, and safety outcomes?
KQ3: Do spinal cord characteristics identified on diffusion
tensor imaging (DTI) predict neurologic, functional,
patient-reported, and safety outcomes?
KQ4: Is there evidence to suggest that baseline MRI is cost-
effective in patients with acute SCI?
Materials and Methods
Electronic Literature Search
We conducted a systematic search of PubMed/MEDLINE,
EMBASE, the Cochrane Collaboration Library, and Google
Scholar for literature published through May 12, 2015. Cita-
tions with abstracts of human studies were considered for inclu-
sion, with no other limits (including language) applied to the
search. Reference lists of included studies as well as pertinent
reviews were systematically checked to identify additional arti-
cles. A summary of the search strategy is presented in the
supplemental material (available in the online version of the
article).
The search strategy included the use of controlled vocabulary
(MeSH terms) as well as keywords. Terms specific to traumatic
spinal cord injuries and central cord syndrome as well as those
related to MRI and DTI were used. For KQ1, we sought to
identify comparative studies that assessed if presurgical MRI
influenced management strategies and, consequently, neurolo-
gic, functional, patient-reported, and safety outcomes. For KQ1
and KQ4, we only included studies that compared specific treat-
ment strategies (eg, emergency decompressive surgery), out-
comes (KQ1), or cost-effectiveness data (KQ4) between
groups that did and did not receive presurgical MRI. For KQ2
and KQ3, we attempted to identify prospective or retrospective
cohort studies that evaluated lesion characteristics, pattern, and/
or length on conventional MRI (KQ2) or DTI (KQ3) as predic-
tors of neurologic change/recovery (eg, Frankel grade, American
Spinal Injury Association [ASIA] impairment scale [AIS]), func-
tional outcomes (eg, Functional Impairment Measure [FIM]),
patient-reported outcomes (eg, pain), and safety (eg, complica-
tions and adverse events). For KQ4, we sought comparative
full-economic studies that evaluated the cost-effectiveness of
presurgical MRI in patients with acute SCI. Meeting abstracts/
proceedings, white papers, editorials, narrative reviews, case
reports, nonclinical and animal studies, and studies with less than
10 subjects in total (KQ2 and KQ3) or per group (KQ1 and KQ4)
were excluded. Studies on patients with cord compression/spinal
cord injuries due to degenerative disease (eg, cervical spondy-
lotic myelopathy, spinal stenosis), tumor, or hematoma were also
excluded. The PICO (Patients, Intervention, Comparator and
Outcomes) and PPO (Patients, Prognostic Factors and Out-
comes) tables provide additional information on inclusion/exclu-
sion criteria (Tables 1 and 2).
Data Extraction
The full texts of potential articles were reviewed by 2 indepen-
dent investigators (DJF, ACS) to obtain the final collection of
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included studies. From the included articles, the following data
was extracted: study design; patient demographics; inclusion
and exclusion criteria; baseline population/disease characteris-
tics; follow-up duration and the rate of follow-up (if reported or
calculable); baseline MRI characteristics and assessment;
timing of MRI in relation to injury and intervention (if appli-
cable); treatment groups (KQ1); reported information on spe-
cific treatment decisions (KQ1); neurological, functional,
safety, and quality of life outcomes (KQ1, KQ2, and KQ3);
prognostic factors evaluated (KQ2 and KQ3); association
Table 1. PICO Table Summarizing Inclusion and Exclusion Criteria for Key Questions 1 and 4.
Study
Component Inclusion Exclusion
Patient  Adult patients with acute traumatic spinal cord injury (complete or
incomplete)
 Adult patients with central cord syndrome
 Pediatric patients <18 years old
 Pregnancy
 Penetrating injuries to spinal cord
 Cord compression/injury due to tumor,
hematoma, degenerative disease (eg, CSM, spinal
stenosis)
 Patients without neurologic deficit following
trauma
 <80% of study population with a diagnosis of acute
spinal cord injury and/or central cord syndrome
Intervention  Baseline MRI was performed  Studies that utilized low-resolution MRI (<1.0
Tesla)
Comparator  No baseline MRI was performed
Outcomes  Treatment strategies
 Surgical
 Nonsurgical
 Neurologic change/recovery (eg, Frankel grade, ASIA Motor/
Sensory score, ASIA Impairment Scale [AIS] grade)
 Change in neurologic grade
 Change in motor scores
 Change in sensation
 Functional change/recovery (eg, FIM)
 Change in functional score
 Change in ambulation
 Survival
 Patient-reported outcomes
 Safety outcomes
 Complications, adverse events
 Postinjury medical complications
 Incremental cost-effectiveness ratio (ICER) (KQ4 only)
 Synthesized cost with effectiveness or utility
measure not reported (KQ4 only)
Study design  KQ1: Studies that evaluate treatment strategies and neurologic,
functional, patient-reported, and/or safety outcomes in patients who
underwent presurgical MRI compared to those who did not
 KQ4: Studies that evaluate the cost-effectiveness of treatment
strategies and neurologic, functional, patient-reported, and/or safety
outcomes in patients who underwent presurgical MRI compared to
those who did not
 Focus will be on studies with the least potential for bias (RCTs and
nonrandomized comparative studies)
 No multivariate analysis of primary outcome(s) of
interest
 Case reports
 Studies of <10 subjects per group
 Nonclinical studies
 Animal studies
Publication
type
 Studies with abstracts in peer-reviewed journals  White papers
 Abstracts, conference proceedings
 Editorials, letters to editor
 Articles identified as preliminary reports with
results published in later versions
 Narrative reviews
 Duplicate publications of the same study which do
not report on different outcomes
 Multiple studies on the same patient population
 Single reports from multicenter trials
Abbreviations: ASIA, American Spinal Injury Association; CSM, cervical spondylotic myelopathy; FIM, Functional Impairment Measure; KQ, key question; MRI,
magnetic resonance imaging; RCT, randomized controlled trial.
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Table 2. PPO Table Summarizing Inclusion and Exclusion Criteria for Key Questions 2 and 3.
Study
Component Inclusion Exclusion
Patient  Adult patients with acute traumatic spinal cord injury
(complete or incomplete)
 Adult patients with central cord syndrome
 Pediatric patients <18 years old
 Pregnancy
 Penetrating injuries to spinal cord
 Cord compression/injury due to tumor, hematoma,
degenerative disease (eg, CSM, spinal stenosis)
 Patients without neurologic deficit following trauma
 <80% of study population with a diagnosis of acute spinal
cord injury and/or central cord syndrome
Prognostic
factor
 Primary factor
 Spinal cord lesion characteristics on MRI (eg, spinal cord
compression, spinal canal compromise; KQ2)
 Spinal cord lesion pattern and/or length on MRI (eg,
hematoma, edema; KQ2)
 Spinal cord lesion characteristics on diffusion tensor
imaging (DTI) MRI (KQ3)
 Secondary (potentially confounding) factors:
 Timing of MRI after injury
 Age
 Patient comorbidities
 Neurologic status (eg, Frankel grade, ASIA Impairment
Scale [AIS] grade)
 Treatment strategies
 Studies that utilized low-resolution MRI (<1.0 Tesla)
Outcomes  Neurologic change/recovery (eg, Frankel grade, ASIA Motor/
Sensory score, AIS grade)
 Change in neurologic grade
 Change in motor scores
 Change in sensation
 Functional change/recovery (eg, FIM)
 Change in functional score
 Change in ambulation
 Survival
 Patient-reported outcomes
 Safety outcomes
 Complications, adverse events
Study design  Studies that evaluate the ability of lesion characteristics,
pattern, and/or length on MRI to predict outcomes
 Focus will be on studies with the least potential for bias
(prospective and retrospective cohort studies)
 No multivariate analysis of primary outcome(s) of
interest
 Did not control for baseline neurologic function in
analysis
 No longitudinal follow-up
 Case reports
 Studies of <10 subjects
 Nonclinical studies
 Animal studies
Publication
type
 Studies with abstracts in peer-reviewed journals  White papers
 Abstracts, conference proceedings
 Editorials, letters to editor
 Articles identified as preliminary reports with results
published in later versions
 Narrative reviews
 Duplicate publications of the same study which do not
report on different outcomes
 Multiple studies on the same patient population
 Single reports from multicenter trials
Abbreviations: ASIA, American Spinal Injury Association; CSM, cervical spondylotic myelopathy; FIM, Functional Impairment Measure; MRI, magnetic resonance
imaging.
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between prognostic factors and reported outcomes (KQ2 and
KQ3); and cost-effectiveness data (KQ4).
Study Quality and Overall Strength of Body of Literature
Each article was independently critically appraised and evalu-
ated for risk of bias by at least 2 reviewers (DJF, ACS) using
criteria set by The Journal of Bone and Joint Surgery, Amer-
ican Volume5 for prognostic and therapeutic studies, and mod-
ified to delineate criteria associated with methodological
quality and risk of bias based on recommendations made by
the Agency for Healthcare Research and Quality (AHRQ).6
This appraisal system accounts for features of methodologic
quality and important sources of bias by combining epidemio-
logic principles with characteristics of study design.7,8 (See
Supplemental Material for study ratings; available in the online
version of the article.) Any disagreement among the reviewers
was resolved through discussion.
The overall quality (strength) of the body of evidence with
respect to each outcome was determined based on precepts
outlined by the Grades of Recommendation Assessment,
Development and Evaluation (GRADE) Working Group9,10
and recommendations made by AHRQ.6 Additional qualitative
analysis was performed according to AHRQ-required (risk of
bias, consistency, directness, precision) and additional domains
(dose-response, strength of association, publication bias).11 In
general, risk of bias was determined when evaluating each
individual article as described above.
For outcomes related to KQ1, the initial quality of the over-
all body of evidence was considered “High” for randomized
controlled trials and “Low” for observational studies. The body
of evidence could be downgraded 1 or 2 levels based on the
following criteria: (1) risk of bias (study limitations), (2) incon-
sistency of results, (3) indirectness of evidence, (4) imprecision
of the effect estimates (eg, wide confidence intervals), or (5)
failure to provide an a priori statement of subgroup analyses.
The body of evidence for observational studies could be
upgraded 1 or 2 levels (if no serious risk of bias) based on the
following criteria: (1) large magnitude of effect, (2) dose-
response gradient, or (3) if all plausible biases would decrease
the magnitude of an apparent effect. For KQ2 and KQ3, the
initial quality of the evidence was considered “High” if the
majority of prognostic studies had low or moderately low risk
of bias, and “Low” if the majority had moderately high or high
risk of bias. The body of evidence could be downgraded 1 or 2
levels based on the following criteria: (1) inconsistency of
results, (2) indirectness of evidence, (3) imprecision of the
effect estimates (eg, wide confidence intervals, small sample
size), or (4) failure to provide an a priori statement of subgroup
analyses. The body of evidence could be upgraded based on the
criteria specified above. Two senior systematic review metho-
dologists rated and discussed the overall quality of evidence.
The final overall strength of the body of literature expresses
(1) our confidence that the effect size lies close to the true
effect and (2) the extent to which the effect is believed to be
stable based on the adequacy of or deficiencies in the body of
evidence.10 An overall strength of “High” means that we are
very confident that the true effect lies close to that of the
estimated effect. A “Moderate” rating means that we are mod-
erately confident in the effect estimate; the true effect is likely
to be close to the estimated effect, but there is a possibility that
it is substantially different. An overall strength of “Low” means
that our confidence in the effect estimate is limited; the true
effect may be substantially different from the estimate. Finally,
a rating of “Very Low” means that we have very little confi-
dence in the effect estimate; the true effect is likely to be
substantially different from the estimated effect. In addition,
this rating may be used if there is no evidence or it is not
possible to estimate an effect.
Data Synthesis and Analysis
For KQ1, results and comparative statistics regarding treatment
decisions and neurologic outcomes were reported. For KQ2,
there was variability in the measurement and reporting of prog-
nostic factors and outcomes. To operationalize outcomes and
discern patterns of association, we combined outcomes into 2
categories: neurologic and functional. The latter category
included 2 patient-reported outcomes (self-reports of manual
dexterity and dysesthetic pain) that may ultimately affect func-
tion. Furthermore, authors generally did not report the magni-
tude of association (eg, effect size estimates with confidence
intervals) between predictive characteristics and outcomes, but
rather presented P values and/or stated whether there was a
significant association. We reported the association between
the prognostic factor and the specific outcome (no association,
association with a negative outcome, or association with a
positive outcome).
Results
Study Selection
The literature search yielded 796 potentially relevant citations
that were evaluated against a priori inclusion/exclusion criteria
(Tables 1 and 2; Figure 1). After title/abstract review, 741 were
excluded, most of which reported on bony fractures or other
acute trauma without SCI. Review of the reference lists of
included studies as well as relevant reviews did not yield any
additional relevant citations. Among the 55 remaining articles,
47 were excluded after review by 2 reviewers. The primary
reasons for exclusion were (1) failure to control for confound-
ing factors (especially baseline neurologic status) via multi-
variate analysis or other statistical methods and (2) the lack
of longitudinal information on neurologic or functional
recovery.
For studies evaluating the impact of MRI on clinical deci-
sion making, the primary reason for exclusion was the lack of a
comparison group with patients that did not receive MRI
(KQ1). Additional reasons for exclusion were (1) the absence
of outcomes of interest (KQ1, KQ2), (2) the lack of a multi-
variate analysis or other statistical methods to control for
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important confounders (particularly baseline neurologic status;
KQ2), and (3) no assessment of MRI prognostic factors (KQ2,
KQ3). We identified a single study for KQ1 that compared
treatment decisions and neurological outcomes between
patients with and without pretreatment MRI; 7 studies for
KQ2 that evaluated important MRI predictors of outcomes; and
no studies relevant for either KQ3 or KQ4. Details of excluded
articles are provided in the Supplemental Material (available in
the online version of the article).
The Influence of Baseline MRI on Treatment Strategy(ies)
and SCI Outcomes
One prospective cohort study12 (moderately high risk of bias)
evaluated the effect of pretreatment MRI on neurological out-
come (Frankel grade). Table 3 summarizes the characteristics
of this study, while Table 4 reports the influence of a baseline
MRI on neurologic outcomes.
Papadopoulos et al reported on 91 consecutive patients suf-
fering from traumatic closed cervical (C1-T1) SCI.12 Sixty-six
(72.5%; protocol group) acute SCI patients were managed
according to a decision-making protocol (MRI-protocol group)
in which the MRI results were used to decide on emergency
surgical decompression. This study reported that MRI resulted
in no adverse events in all 66 patients and identified ongoing
cord compression in 34/66 (51.5%) patients receiving MRI,
leading to surgical treatment (mean 9.6 hours after hospital
arrival, 13.4 hours postinjury). MRI also identified anterior
spinal cord compression (disc herniation, epidural hematoma,
malalignment, or bone fragments) in 16/66 patients (24.2%),
leading to an anterior surgical approach. The remaining 25
patients (27.5%; reference group) were not managed according
to the protocol because of a contraindication to performing
MRI, the need for an emergent surgical procedure, or “specific
surgeon bias regarding the futility of emergent treatment.”
These criteria for group assignment indicate a strong potential
for selection bias. The MRI-protocol group was 68.2% (45/66)
male with a mean age of 32+ 2.1 (range 2-92) years, while the
reference group was 76.0% (19/25) male with a mean age of 42
+ 4.8 (range 2-89) years. The neurologic follow-up interval for
patients in the protocol group was on average 31.6 + 3.6
(range 2-92) months, while patients in the reference group had
a mean follow-up of 36.2 + 5.7 (range 2-96) months. Unfor-
tunately, details regarding management for the reference group
Figure 1. Flow chart showing results of literature search.
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were not reported, and thus no direct comparisons could be
made between the groups regarding the impact of MRI on
treatment decisions.
The effect of acquiring a baseline MRI (and treatment pro-
tocol) was evaluated in a linear regression analysis that
adjusted for baseline Frankel grade, age, sex, mechanism of
injury, admitting injury level, and admitting Injury Severity
Score. Patients in the MRI-protocol group, on average, had
an improved Frankel grade compared to those in the reference
group (0.7 of a Frankel grade, P < .006). Fifty percent of the
MRI-protocol group experienced an improvement in Frankel
grade, compared to 24% of the reference group. Eight patients
(12%) in the MRI-protocol group improved from a motor-
complete injury to independent ambulation, whereas no
patients in the reference group patients achieved this
improvement.
Table 3. KQ1 Characteristics of Studies Evaluating the Impact of MRI on Clinical Decision Making and Neurologic, Functional, Pain, and/or
Safety Outcomes Compared to No MRI.
Study Demographics
Baseline Population Definition
and Characteristics Treatment Groups
Baseline MRI
Characteristics and Timing
Outcome
Measures
Evaluateda
Papadopoulos
(2002)
Prospective
cohort
Risk of bias:
Moderately
high
Protocol group:
N ¼ 66
Sex: 68.2%
(45/66)
male
Mean age: 32
+ 2.1 (2-
92) years
F/U: 31.6+
3.6 (2-92)
months
F/U %: NR
Reference
group:
N ¼ 25
Sex: 76.0%
(19/25)
male
Mean age: 42
+ 4.8 (2-
89) years
F/U: 36.2+
5.7 (2-96)
months
F/U %: NR
Population: 91 consecutive
patients suffering from
traumatic closed cervical
(C1-T1) SCI who received
acute care. Patients were
either managed by a
treatment protocol
(protocol group) or were
part of a reference group.
Admitting Frankel score
Protocol group
 Frankel Grade A: 57.6%
(38/66)
 Frankel Grade B: 18.2%
(12/66)
 Frankel Grade C: 13.6%
(9/66)
 Frankel Grade D: 10.6%
(7/66)
Reference group
 Frankel Grade A: 64.0%
(16/25)
 Frankel Grade B: 16.0%
(4/25)
 Frankel Grade C: 0.0% (0/
25)
 Frankel Grade D: 20.0%
(5/25)
 Protocol group (n ¼ 66):
Patients with cervical spinal
malalignment causing
suspected SCC were
placed in skeletal traction.
Once optimal spinal
alignment was achieved,
patients underwent MRI.
Patients with MRI-
documented SCC
underwent emergency
surgical decompression and
spinal column stabilization.
Patients without SCC were
treated with either surgery
for internal spinal column
stabilization within 24-48
hours or placed in a
definitive external orthosis.
 Reference group (n¼25):
Reference group patients
were treated outside of the
protocol because of
contraindication to MRI,
the need for an emergent
surgical procedure, or
admitting surgeon
preferences.
MRI characteristics: T1- and
T2-weighted MR imaging
of the cervical spine was
performed with 1.5-Tesla
scanner (protocol group
only)
MRI assessment: NR
MRI timing with regard to
injury: Mean time from
injury to MRI was 7.7+
0.4 hoursb (for protocol
group only)
MRI timing with regard to
intervention: Mean time
from injury to operative
decompression was 12.6
+ 1.3 hoursb
Neurologic
 Frankel
grade at last
follow-up
Potential
confounding
factors
Demographic
 Age
 Sex
Clinical
 Mechanism
of injury
 Admitting
injury level
 Admitting
Injury
Severity
Score
 Admitting
Frankel
grade
Abbreviations: F/U, follow-up; MRI, magnetic resonance imaging; NR, not reported; SCC, spinal cord compression; SCI, spinal cord injury.
aOnly reported outcome measures related to study question.
bReported as mean+ standard error.
Table 4. The Impact of Baseline MRI on Treatment Strategies and Neurologic, Functional, and Safety Outcomes in Patients With Acute Spinal
Cord Injury.
Author (Year) Risk of Bias Outcome Measures
Follow-up Duration
(Months)
Protocol Group
(N ¼ 66)
Reference Group
(N ¼ 25) P Value
Papadopoulos
(2002)
Moderately
high
Frankel grade improvement
(last follow-up)
2-92 NR NR P < .006a
Protocol >
Referenceb
Abbreviations: MRI, magnetic resonance imaging; NR, not reported.
aP value reported by the authors based on results of multivariate regression analysis that accounted for potential confounders (age, sex, mechanism of injury,
admitting injury level, admitting Injury Severity Score, admitting Frankel grade).
bPatients in the Protocol group improved 7/10 of a Frankel grade more than patients in the Reference group.
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Spinal Cord Lesion Characteristics, Pattern, and Length
Identified on Baseline MRI as Predictors of SCI Outcomes
Table 5 summarizes the characteristics of the included prog-
nostic studies. Of these, 4 prospective cohort studies13-16 and 1
retrospective cohort study17 were considered to have moder-
ately low risk of bias, and 2 retrospective cohort studies18,19
were considered to have moderately high risk of bias. All stud-
ies controlled for baseline neurologic status in multivariate
models and followed populations for the primary outcome(s)
of interest. One included study (Selden et al) reported the
importance of baseline neurological status and various MRI
findings in predicting neurological outcomes; however, model
details were not provided and results were only assumed to be
multivariate.
Across studies, there was variability in the reporting and
measurement of prognostic factors and outcomes. Adjusted
effect sizes and/or confidence intervals describing the magni-
tude of association between the predictive factor(s) and out-
come were rarely reported. Only a single study17 reported a
follow-up of >80% of subjects. One study13 compared findings
in patients with complete SCI to those with incomplete SCI and
also performed a post hoc subgroup analysis in only patients
with complete SCI.
Across the included studies, the majority of the patient pop-
ulation was male (65.5% to 87.5%) with a wide range of mean
ages (29-58 years). Four studies limited their population to
patients with cervical SCI.13,14,18,19 MRI was performed within
3 days of injury in most studies, with one reporting a median of
8 days (range 5-12 days). The timing from MRI to intervention
was inconsistently reported. Follow-up time ranged from 1 to
74 months.
MRI Predictors of Neurologic Recovery
The association between MRI features and neurological
outcomes was reported in 6 studies. For evidence synth-
esis, the following measures were considered together: AIS
grade, Frankel grade, ASIA Motor score, motor function
score, upper/lower extremity motor function and minimally
useful function, pin prick score, and light touch score (see
Table 6). A detailed table of associations is provided in the
supplemental material (available in the online version of
the article).
The association between neurological outcomes and the
presence of intramedullary spinal cord hemorrhage (defined,
in the acute period, as a region of decreased signal intensity
surrounded by a thin rim of high signal intensity on T2-
weighted images) was investigated in 5 studies, each of which
used a different assessment measure. Based on multivariate
analysis, 2 studies found no association,13,15 while 3 studies
reported that the presence of hemorrhage is predictive of
worse neurologic recovery.14,18,19 In the study by Selden
et al, intra-axial hematoma was present in all Frankel grade
A patients, none of whom experienced a change in Frankel
grade at follow-up.19
Longer rostro-caudal intramedullary hematoma length was
associated with worse neurologic recovery in 2 studies.13,19
Boldin et al reported that each millimeter increase in hematoma
length increased the risk of retaining a complete SCI; patients
with complete SCI tended to have a longer hematoma length
(median 10.5mm, range 4-15mm) than those with incomplete
injuries (median 4mm, range 2-9mm) and did not exhibit a
change in AIS grade at follow-up. This study also reported that
5 patients with a hemorrhage length less than 4mm demon-
strated improvements on the AIS grade at follow-up, suggest-
ing that a length less than 4mm may be predictive of positive
outcomes.13 Based on a single study, cord compression from
extra-axial hematoma was not associated with poorer neurolo-
gic recovery in multivariate analysis.19
The association between maximal canal compromise
(MCC) and neurologic recovery was inconsistent across 2 stud-
ies. One study14 found no association, while the other17
reported that a lower MCC is predictive of a worse neurologic
recovery. Maximum spinal cord compression (MSCC) was not
associated with neurologic recovery across 3 studies.14,17,19
The association between neurological outcomes and MRI
evidence of cord edema (defined as a region of high signal
intensity on T2-weighted images) was evaluated in 3 studies,
each of which used a different assessment measure. Presence of
cord edema was not associated with neurologic recovery in all
3 studies.13-15 Longer edema lesion length, however, was pre-
dictive of a worse neurologic recovery in 2 studies.13,18 In a
third study, a significant association was observed between
edema lesion length and neurologic recovery following uni-
variate analysis but not following what appears to be multi-
variate analysis (authors do not provide details of multivariate
analysis and cautious interpretation is advised).19
Two studies reported no association between SCI lesion
length and neurologic recovery.14,17 Cord swelling (defined
as an increased spinal cord diameter) was predictive of worse
neurological outcomes in one study;14 a second study indicated
no association between length of cord swelling and neurologic
recovery.19 Finally, single studies suggested no association
between the following MRI radiographic factors and neurolo-
gic recovery: smaller diameter within swollen length of the
cord, soft-tissue injury, preinjury stenosis, disk herniation, cord
contusion, rostral point of edema, and worse baseline pin prick,
light touch, and motor function scores.
MRI Predictors of Functional Recovery
The association betweenMRI features and functional outcomes
was reported in 2 studies.16,17 For evidence synthesis, the fol-
lowing measures of functional recovery were considered
together: FIM Motor score, functional dependence (dichoto-
mous variable based on FIM score), and self-reported measures
of manual dexterity and dysesthetic pain (see Table 6). A
detailed table of associations is provided in the supplemental
material (available in the online version of the article).
In a single study, lower MCC was significantly associated
with worse FIM score, but not with patient-reported measures
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Table 6. Association Between MRI and Other Factors and Neurologic, Functional, and Pain Outcomes.
Outcome Measuresa
Potential Prognostic Factors Neurologic Recoveryb
Functional and Pain
Recoveryc
Radiographic
Lower MCC O (Miyanji)/ (Aarabi) O/ (Aarabi)
Lower MSCC O (Aarabi, Miyanji, Selden) O (Aarabi)
Smaller spinal canal diameter at MSCC (mm) – (Aarabi) O (Aarabi)
Smaller diameter within swollen length of cord O (Selden)
Longer SCI lesion length (mm) O (Aarabi, Miyanji) O/ (Aarabi)
Cord edema O (Boldin, Miyanji, Shepard)
Intramedullary hemorrhage or intra-axial hematoma O (Boldin, Shepard)/ (Miyanji, Flanders,
Selden)
Edema or hemorrhage O (Wilson)
Cord swelling  (Miyanji)
Soft-tissue injuryd O (Miyanji)
Preinjury stenosis O (Miyanji)
Disk herniation O (Miyanji)
Cord contusion O (Shepard)
Longer edema lesion length O (Boldin, Selden)/ (Flanders)
Rostral point of edema O (Flanders)
Longer hemorrhage lesion or cord hematoma length  (Boldin, Selden)e
Longer cord swelling length O (Selden)
Secondary (potentially confounding) factors
Demographic
Older age O (Aarabi) O//þ (Aarabi, Wilson)
Clinical
Lower ASIA Impairment Score (Admission) O (Boldin, Miyanji)  (Wilson)
Lower ASIA Motor Score (Admission)  (Aarabi, Miyanji, Flanders) O/ (Aarabi)
ASIA Motor Score  50  (Wilson)
Lower Frankel Score (Admission)  (Selden)
Worse baseline pin prick scorey O (Shepard)
Worse baseline light touch scorey O (Shepard)
Worse baseline motor function scorey O (Shepard)
Mechanism of injury O (Aarabi) O (Aarabi)
Number of stenotic skeletal segments O (Aarabi) O (Aarabi)
Surgical technique (front, back, circumferential
decompression)
O (Aarabi) O (Aarabi)
Time delay after injury until surgery O (Aarabi) O (Aarabi)
Abbreviations: ASIA, American Spinal Injury Association; FIM, Functional Independence Measure; MCC, maximum canal compromise; MRI, magnetic resonance
imaging; MSCC, maximum spinal cord compression; NS, not significant; SCI, spinal cord injury.
(O) ¼ no association; () ¼ association with a negative outcome; (O/) ¼ no association in one publication or with one outcome, association with a negative
outcome in a second publication or with another outcome; (O//þ) ¼ no association in one publication or with one outcome, association with a negative
outcome in a second publication or with another outcome, association with a positive outcome in a third publication or with another outcome.
aResults presented as reported by the authors based on multivariate regression analyses, adjusted for baseline neurologic status.
bNeurologic recovery: ASIA Impairment Scale grade, Frankel grade, ASIA Motor score, motor function score, upper/lower extremity motor function and minimally
useful function, pin prick score, light touch score. Motor function score was determined by bilaterally measuring 14 muscle roots, with 0 ¼ no contraction, 1 ¼
flicker/trace of contraction, 2 ¼ active movement without antigravity, 3 ¼ active movement with antigravity, 4 ¼ active movement against resistance, and 5 ¼
normal. The responses for the right side were summed and ranged from 0 to 70. Extremity motor function was assessed by testing key individual muscles in each of
the upper and lower extremities. Each muscle received a score of 0 to 5 for a total possible motor index score of 50 for upper extremity function and 40 for lower
extremity function. Minimally useful motor function in an individual muscle was defined as a score of 3 or better on the 5-point manual muscle test. A score of 3
represents the ability for active movement with a full range of motion against gravity. Pin prick/light touch score was determined as follows: 29 spinal cord segments
were tested bilaterally for response to pin prick and light touch, each of which were scored at 1 ¼ absent, 2 ¼ dysfunctional, and 3 ¼ normal. Sensory scores
ranged from a total score of 87 (normal response) to a score of 29 (no response in any segment). Responses for the right side were summed, unless some cord
segments could not be tested, in which case responses for the left side were used.
cFunctional recovery: FIM Motor Score, functional dependence, manual dexterity, dysesthetic pain. Functional dependence was a dichotomous variable defined as
having achieved/not achieved6 for all 13 FIM score items.Manual dexterity level was defined as the patient’s own perception of dexterity and skill in the following
tasks: (1) using a keyboard, (2) playing a musical instrument, (3) buttoning his/her shirt, (4) grooming, and (5) writing. Dysesthetic pain levelwas a subjective rating on
a 0 to 10 analog scale.
dMiyanji (2007): Soft-tissue injury was defined as an increased signal intensity of the perivertebral tissues on T2-weighted images.
eWhen length of hematoma was added to the statistical model, the only significant predictor in the model was length of hematoma.
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of manual dexterity and dysesthetic pain.17 MSCC and the
spinal canal diameter at MSCC were not predictive of any
measure of functional recovery.17 There was no associa-
tion between SCI lesion length and FIM score; however, a
longer SCI lesion length was related to worse manual
dexterity and dysesthetic pain.17 Finally, based on a single
study, MRI signal characteristics consistent with edema or
hemorrhage are not important predictors of functional
outcomes.16
Spinal Cord Lesion Characteristics, Pattern, and Length
Identified on Baseline Diffusion Tensor Imaging MRI as
Predictors of SCI Outcomes
No studies were identified that assessed the association
between DTI characteristics and outcomes.
Cost-Effectiveness of Baseline MRI in Patients With
Acute SCI
No full economic analyses were identified that assessed the
cost-effectiveness or cost utility of MRI in patients with acute
SCI.
Evidence Summary
For KQ1, the overall quality of evidence was “Very Low” that
patients who received a baseline MRI had an average improve-
ment of 0.7 in Frankel grade compared to those who did not
receive an MRI. Definitive conclusions are not possible from
this study due to risk of bias (selection bias), lack of precision,
and lack of data regarding the outcome of interest; specifically,
details on the impact of MRI on clinical decision making were
not reported (Table 7).
For KQ2, Tables 8 and 9 summarize the overall quality
of evidence for prognostic factors. There is “Moderate”
quality evidence that longer intramedullary hemorrhage and
“Low” quality evidence that smaller spinal canal diameter at
MSCC are associated with decreased neurologic recovery.
There is “Moderate” evidence that lower MSCC, longer SCI
lesion length, and cord edema are not associated with worse
neurologic recovery. There is inconsistent evidence that
presence of hematoma (“Low”), greater edema lesion length
(“Very Low”), cord swelling (“Low”), and MCC (“Low”)
are predictive of worse neurologic recovery. MCC was the
only significant predictor of worse functional outcome
(“Low”). There is substantial heterogeneity across these
studies with respect to the prognostic factors evaluated as
well as in definitions and methods of measurement. Further-
more, there is variability in the measures used to evaluate
outcomes, limiting our ability to synthesize findings across
studies. In most instances, effect sizes and confidence inter-
vals were not provided, preventing the evaluation of preci-
sion and magnitude of effect.
The following list summarizes the findings from the
included prognostic studies (Tables 8 and 9):
 Longer hemorrhage length (“Moderate Evidence”):
Two studies observed an association between longer
hemorrhage length and worse neurologic recovery.
Of these, one reported substantially longer hema-
toma length in ASIA A patients (no change in Fran-
kel grade by follow-up) than in ASIA B, C, D
patients (lower Frankel grades at follow-up);
adjusted estimates were available only for patients
with complete SCI.
 Hemorrhage (“Low Evidence”): Three studies reported
an association between the presence of hemorrhage on
MRI and worse neurologic recovery; 2 other studies
found no association. Each used different measures of
neurologic outcome.
 Cord edema: Three studies reported no association
between cord edema and neurologic function; each used
different measures of neurologic outcome (“Moderate
Evidence”). Based on a single study, rostral point of
edema was not predictive of neurologic outcomes
(“Very Low Evidence”).
 Longer edema lesion length (“Very Low Evidence”): A
single study reported an association between longer
edema lesion length and worse neurologic recovery; 2
other studies found no association.
 Lower MSCC: There is no association between
MSCC and either neurologic recovery (“Moderate
Evidence”) or functional recovery (“Low Evidence”).
Three studies reported no association with neurologic
recovery. MSCC and the spinal canal diameter at
MSCC were not predictive of functional outcomes
in one study.
 Lower MCC: One study reported an association between
lower MCC and worse neurologic recovery; another
study found no association (“Low Evidence”). Lower
MCCwas associated with worse FIM scores but not with
manual dexterity or dysesthetic pain in one study (“Low
Evidence”).
 SCI lesion length: Two studies reported no associ-
ation between SCI lesion length and neurologic
recovery (“Moderate Evidence”). Based on a single
study, SCI lesion length was not associated with
FIM score (“Low Evidence”); however, a longer
SCI lesion length was predictive of worse
manual dexterity and dysesthetic pain (“Low
Evidence”).
 Cord swelling (“Low Evidence”): A single study
reported an association between cord swelling and
worse neurologic recovery.
 Length of cord swelling (“Very Low Evidence”): A sin-
gle study reported no association between length of cord
swelling and neurologic recovery.
There were no studies that assessed DTI MRI characteristics
as predictors of SCI outcome (KQ3) or the cost-effectiveness of
MRI (KQ4); there is therefore insufficient evidence to draw
conclusions for these questions.
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Table 8. Quality (Strength) of Evidence Summary for MRI Predictors of Neurological Recoverya.
Prognostic
Factor Studies; N; Follow-up Inconsistency Indirectness Imprecision
Overall
Quality of
Evidence Conclusions, Effect Size
Lower MCC 1 Prospective cohort
(Miyanji, 2007); 1
Retrospective
cohort (Aarabi,
2011)
N ¼ 142
13.7 months
Inconsistent No serious
indirectness
Serious risk of
imprecisionb
Low Results were inconsistent across 2
studies with moderately low risk of
bias. A large prospective study
reported no association between
MCC and neurological outcomes
(no effect estimates or P values
provided, Miyanji), while a second
study demonstrated an association
between a lower MCC and worse
ASIA motor scores (P ¼ .02, no
effect size estimates or confidence
intervals were provided, Aarabi).
Lower MSCC 1 Prospective cohort
(Miyanji, 2007); 2
Retrospective
cohorts (Aarabi,
2011; Selden, 1999)
N ¼ 197
15.1 months
No serious
inconsistency
No serious
indirectness
Serious risk of
imprecisionb
Moderate Three studies (2 with moderately low
risk of bias, 1 with moderately high
risk of bias) reported no association
between lower MSCC and
neurologic recovery. None of these
studies provided effect size
estimates or confidence intervals.
Smaller spinal
canal
diameter at
MSCC (mm)
1 Retrospective cohort
(Aarabi, 2011)
N ¼ 42
12 months
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Low In one small study with moderately
low risk of bias, smaller spinal canal
diameter at MSCC was associated
with worse neurologic recovery
(ASIA motor score, P ¼ .02; no
effect sizes or confidence intervals
provided).
Smaller
diameter
within
swollen
length of
cord
1 Retrospective cohort
(Selden, 1999)
N ¼ 55
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Low A single study with moderately high
risk of bias reported no association
between diameter within swollen
length of cord and neurologic
recovery; no effect sizes or
confidence intervals were provided.
Longer SCI
lesion length
(mm)
1 Prospective cohort
(Miyanji, 2007); 1
Retrospective
cohort (Aarabi,
2011)
N ¼ 142
13.7 months
No serious
inconsistency
No serious
indirectness
Serious risk of
imprecisionb
Moderate Two studies with moderately low risk
of bias reported no association
between longer SCI lesion length
and neurologic recovery; no effect
size estimates or confidence
intervals were provided in either
study.
Cord edema 3 Prospective cohorts
(Miyanji, 2007;
Shepard, 1999;
Boldin, 2006)
N ¼ 320
6.3 months
No serious
inconsistency
No serious
indirectness
Serious risk of
imprecisionb
Moderate Three studies with moderately low
risk of bias reported no association
between cord edema and
neurologic recovery. Only one of
these provided an adjusted effect
size at 6 weeks. Change in motor
score (3.34, P ¼ .06) and light
touch recovery (3.41, P ¼ .05)
suggest reduced neurologic
function and a negative association;
however, these results were
borderline insignificant.
Furthermore, change in pin prick
recovery (2.46, P ¼ .16) was not
statistically significant (Shepard).
(continued)
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Table 8. (continued)
Prognostic
Factor Studies; N; Follow-up Inconsistency Indirectness Imprecision
Overall
Quality of
Evidence Conclusions, Effect Size
Intramedullary
hemorrhage
or intra-axial
hematoma
3 Prospective cohorts
(Boldin, 2006;
Miyanji, 2007;
Shepard, 1999); 2
Retrospective
cohorts (Flanders,
1996; Selden, 1999)
N ¼ 479
6 weeks to 17.4
months
Inconsistent No serious
indirectness
Serious risk of
imprecisiond
Low Across 5 studies (3 with moderately
low risk of bias, 2 with moderately
high risk of bias), presence of
hemorrhage or hematoma was
inconsistently associated with
worse neurologic recovery. In 3
studies (Miyani, P ¼ .002; Selden,
P < .001; Flanders, P < .001),
hematoma or hemorrhage was
significantly predictive of worse
neurologic recovery; none of these
studies provided adjusted effect
sizes or confidence intervals. Two
other studies reported no
association with outcome: (1) one
provided adjusted effect estimates
for neurologic recovery at 6 weeks
(change in motor score: 2.7, P ¼
.29, pin prick recovery: 0.63, P ¼
.79, light touch recovery: 0.93,
P¼ .69 (Shepard)) and (2) the other
did not provide a P value on a
subanalysis of patients with ASIA A
injuries (Boldin).
Cord swelling 1 Prospective cohort
(Miyanji, 2007)
N ¼ 100
7.3 months
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Low In one study with moderately low risk
of bias, the association between
cord swelling and neurologic
recovery (ASIA motor score) was
borderline insignificant (P ¼ .054) in
a multivariate model that included
hemorrhage; no effect size
estimates or confidence intervals
were provided.
Soft-tissue
injuryb
1 Prospective cohort
(Miyanji, 2007)
N ¼ 100
7.3 months
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Low A single study reported no association
between soft tissue injury and
worse neurologic recovery (ASIA
motor score); no P value, effect size
estimates or confidence intervals
were provided.
Preinjury
stenosis
1 Prospective cohort
(Miyanji, 2007)
N ¼ 100
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Low A single study reported no association
between preinjury stenosis and
worse neurologic recovery (ASIA
motor score); no P value, effect size
estimates or confidence intervals
were provided.
Disk herniation 1 Prospective cohort
(Miyanji, 2007)
N ¼ 100
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Low A single study reported no association
between disc herniation stenosis
and worse neurologic recovery
(ASIA motor score); no P value,
effect size estimates or confidence
intervals were provided.
(continued)
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Table 8. (continued)
Prognostic
Factor Studies; N; Follow-up Inconsistency Indirectness Imprecision
Overall
Quality of
Evidence Conclusions, Effect Size
Cord
contusion
1 Prospective cohort
(Shepard, 1999)
N ¼ 191
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Low A single study reported no association
between the presence of cord
contusion and neurological
recovery at 6 weeks (change in
motor score: 0.36, pin prick
recovery: 3.35, or light touch
recovery: 1.38; confidence
intervals were not provided.
Longer edema
lesion length
1 Prospective cohort
(Boldin, 2006); 2
Retrospective
cohorts (Selden,
1999;
Flanders, 1996)
N ¼ 188
17.4 months
Inconsistent No serious
indirectness
Serious risk of
imprecisione
Very Low Across 3 studies (1 prospective study
with moderately low risk of bias and
2 retrospective studies with
moderately high risk of bias), longer
edema length was inconsistently
associated with worse neurologic
recovery.
A single retrospective study reported
that longer edema lesion length was
associated with decreased
extremity function (P ¼ .03 for
decreased upper and lower
extremity function, P < .01 for
lower extremity muscles with
useful function) but not with
decreased upper extremity muscles
with useful function (Flanders). A
second retrospective study also
reported no association between
edema lesion length and neurologic
recovery (P ¼ .071) (Selden).
In the third study, longer edema length
was the only predictor of retaining
complete SCI in patients with or
without hemorrhage. Specifically,
each mm increase in edema length
increased the risk of retaining a
complete SCI (1.15, 95% CI 1.03 to
1.29); however, this variable was no
longer predictive following the
addition of hematoma length to a
multivariate model in 8 patients
with ASIA A injury.
Rostral point
of edema
1 Retrospective cohort
(Flanders 1996)
N ¼ 104
Mean: 12 months
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Very Low A single retrospective study with
moderately high risk of bias
reported no association between
rostral point of edema and
decreased upper or lower
extremity motor function; no
effect size estimates or confidence
intervals were provided.
(continued)
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Discussion
Magnetic resonance imaging has revolutionized the ability of
clinicians to determine the location of traumatic injury in the
spinal cord as well as identify disruptions in tissues that con-
stitute the spinal canal. The purpose of this systematic review
was to assess the role of MRI in clinical decision making and
outcome prediction.
The Role of MRI to Assist Clinical Decision Making (KQ1)
MRI is widely used by many clinicians in the context of acute
SCI to assist with clinical decision making. Unfortunately, our
review only identified a single study (very low evidence) to
address this question. In the study by Papadopoulos et al, the
authors indicated that MRI findings influenced the timing of
surgery with 34/66 (52%) receiving emergency surgery due to
ongoing spinal cord compression and 16/66 (24%) undergoing
anterior surgery due to the presence of anterior cord compres-
sion. As a result, the authors concluded that “emergency MRI
provided an essential tool for the accurate diagnosis of spinal
cord compression and directly influenced (our) initial clinical
management in the majority of protocol patients.” Unfortu-
nately, details regarding the surgical management of the refer-
ence group (no MRI) were not reported, making it impossible
to draw firm conclusions about the utility of MRI in decision
Table 8. (continued)
Prognostic
Factor Studies; N; Follow-up Inconsistency Indirectness Imprecision
Overall
Quality of
Evidence Conclusions, Effect Size
Longer
hemorrhage
lesion or
cord
hematoma
length
1 Prospective cohort
(Boldin, 2006); 1
Retrospective
cohort (Selden,
1999)
N ¼ 84
24.2 months
No serious
inconsistency
No serious
indirectness
Serious risk of
imprecisione
Moderate Across 2 studies (one prospective
study with moderately low risk of
bias and one retrospective study
with moderately high risk of bias),
longer hemorrhage length was
associated with worse neurological
outcome. In the retrospective
study, no effect size estimates or
confidence intervals were provided
(P ¼ .028). In the small prospective
study, longer hemorrhage length
was associated with risk of retaining
a complete SCI in a subgroup
multivariate model in 8 patients
with ASIA A at baseline (OR 1.81
(1.09, 3.02), P ¼ .02) (Boldin).
Longer cord
swelling
length
1 Retrospective cohort
(Selden, 1999)
N ¼ 55
18.5 months
Inconsistency
unknownc
No serious
indirectness
Serious risk of
imprecisionb
Very Low A single retrospective study with
moderately high risk of bias
reported no association between
length of cord swelling and
neurologic recovery.
Adverse events and Safety
Safety
outcomes
NR
Abbreviations: ASIA, American Spinal Injury Association; DTI, diffusion tensor imaging; FIM, Functional Independence Measure; MCC, maximum canal compro-
mise; MSCC, maximum spinal cord compression; MRI, magnetic resonance imaging; NR, no reported studies; SCI, spinal cord injury.
aNeurologic recovery: ASIA Impairment Scale grade, Frankel grade, ASIA Motor score, motor function score, upper/lower extremity motor function and
minimally useful function, pin prick score, light touch score. Motor function score was determined by bilaterally measuring fourteen muscle roots, with 0 ¼ no
contraction, 1 ¼ flicker/trace of contraction, 2 ¼ active movement without antigravity, 3 ¼ active movement with antigravity, 4 ¼ active movement against
resistance, and 5¼ normal. The responses for the right side were summed and ranged from 0 to 70. Extremity motor function was assessed by testing key individual
muscles in each of the upper and lower extremities. Each muscle received a score of 0 to 5 for a total possible motor index score of 50 for upper extremity
function and 40 for lower extremity function. Minimally useful motor function in an individual muscle was defined as a score of 3 or better on the 5-point manual
muscle test. A score of 3 represents the ability for active movement with a full range of motion against gravity. Pin prick/light touch score was determined as follows:
29 spinal cord segments were tested bilaterally for response to pin prick and light touch, each of which were scored at 1 ¼ absent, 2 ¼ dysfunctional, and 3 ¼
normal. Sensory scores ranged from a total score of 87 (normal response) to a score of 29 (no response in any segment). Responses for the right side were
summed, unless some cord segments could not be tested, in which case responses for left side were used.
bNo adjusted effect size estimates and/or no confidence intervals reported.
cSingle study; consistency across studies cannot be assessed for this outcome.
dDowngrade for imprecision: Small sample size for subgroup analysis (8 out of 9 patients with ASIA A) in one study (Boldin) and inability to assess precision as
effect sizes and confidence intervals were not provided in 4 of the 5 studies.
eDowngrade for imprecision: Small sample size for subgroup analysis (8 out of 9 patients with ASIA A) in one study (Boldin) and inability to assess precision in the
other study as effect sizes and confidence intervals were not provided.
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making. A direct comparison, however, was made in terms of
outcome; specifically, patients who received an MRI (and
treatment based on MRI results) exhibited an additional
improvement of 0.7 in Frankel grade compared to those in the
reference group. This study had moderately high risk of bias,
including evidence of strong selection bias. The authors
assigned patients to the reference group (no MRI) due to a
contraindication to MRI, another emergent surgical procedure,
or based on “perceived futility of treatment” by the attending
physician. These criteria for group assignment likely introduce
a systematic bias in subsequent treatment decisions. Thus, the
results of this single study are not sufficient to confidently
suggest that MRI is beneficial in improving decision making.
No other studies were identified that specifically evaluated
differences in treatment decisions, such as surgical timing and
approach, between subject groups with and without pretreat-
ment MRI. As a result, the overall quality of evidence for KQ1
was very low. This lack of evidence suggests that a profound
knowledge gap exists and that future methodologically rigor-
ous comparative studies are needed.
Additional lines of indirect evidence have suggested that MRI
can accurately identify specific clinical entities that may be
important in clinical decision making. A large number of studies
have demonstrated MRI to be useful in identifying ongoing
Table 9. Quality of Evidence Summary for MRI Predictors of Functional Recovery and Paina.
Prognostic Factor
Studies; N;
Follow-up Inconsistency Indirectness Imprecision
Overall
Quality of
Evidence Conclusions, Effect Size
Lower MCC 1 Retrospective
cohort
(Aarabi, 2011)
N ¼ 42
29.1 months
Inconsistency
unknownb
No serious
indirectness
Serious risk of
imprecisionc
Low In one small retrospective cohort study
with moderately low risk of bias, lower
MCC was associated with worse FIM
score at follow-up (P¼ .02) but not with
manual dexterity (P ¼ .10) or
dysesthetic pain (P ¼ .24); no effect size
or confidence intervals were reported.
Lower MSCC Inconsistency
unknownb
No serious
indirectness
Serious risk of
imprecisionc
Low In one small retrospective cohort study
with moderately low risk of bias, lower
MSCC was not associated with worse
FIM score (P ¼ .47), manual dexterity (P
¼ .10), or dysesthetic pain (P ¼ .20); no
effect size or confidence intervals were
reported.
Smaller spinal canal
diameter at
MSCC (mm)
Inconsistency
unknownb
No serious
indirectness
Serious risk of
imprecisionc
Low In one small retrospective cohort study
with moderately low risk of bias, smaller
spinal canal diameter at MSCC was not
associated with worse FIM score (P ¼
.10), manual dexterity (P ¼ .25), or
dysesthetic pain (P ¼ .42); no effect size
or confidence intervals were reported.
Longer SCI lesion
length (mm)
Inconsistency
unknownb
No serious
indirectness
Serious risk of
imprecisionc
Low In one small retrospective cohort study
with moderately low risk of bias, longer
SCI lesion length was associated with
worse manual dexterity (P ¼ .002) and
dysesthetic pain (P ¼ .04) but not with
worse FIM score (P¼ .16); no effect size
or confidence intervals were reported.
MRI signal
characteristics
consistent with
edema or
hemorrhage
1 Prospective
cohort
(Wilson,
2012)
N ¼ 376
6-12 months
Inconsistency
unknownb
No serious
indirectness
Serious risk of
imprecisiond
Low In one prospective cohort study with
moderately low risk of bias, MRI
characteristics consistent with edema
or hemorrhage were not associated
with FIM score (P¼ .19; no effect size or
confidence interval provided) or
functional independence at 12 months
(OR 0.75; no confidence interval
provided; P ¼ .54).
Abbreviations: FIM, Functional Independence Measure; MCC, maximum canal compromise; MSCC, maximum spinal cord compression; MRI, magnetic resonance
imaging; OR, odds ratio; SCI, spinal cord injury.
aFIM ¼ Functional dependence was a dichotomous variable defined as having achieved/not achieved 6 for all 13 FIM score items.
bSingle study; consistency across studies cannot be assessed for this outcome.
cNo adjusted effect size estimates or no confidence intervals reported, therefore cannot assess precision.
dNo confidence interval for the odds ratio was reported, therefore cannot assess precision.
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spinal cord compression, ligamentous injury, disc herniation,
and vertebral artery injury.2 These factors may influence surgical
timing, approach, and need for instrumentation. However, the
vast majority of studies on this topic did not meet our inclusion
criteria as they did not (1) provide information on longitudinal
follow-up, (2) compare decision-making choices between
patients with and without MRI, or (3) provide estimates of
effect on clinical outcomes that adjusted for baseline neurologi-
cal status. Our approach was to focus on studies that evaluated
the effect of MRI on treatment decisions and subsequent out-
comes; unfortunately, only one study satisfied the inclusion cri-
teria for this key question. The systematic review by Bozzo et al2
synthesized a broader pool of studies in the context of acute SCI
and developed a weak recommendation (based on weak evi-
dence) for the use of MRI to direct clinical management. How-
ever, this systematic review had a number of methodological
weaknesses and was rated as poor to moderate quality with a
score of 5/11 on the AMSTAR scale (see supplemental material,
available in the online version of the article). Furthermore, many
of the individual studies (1) either did not report the timing of
MRI relative to injury or surgical intervention or reported a
broad range of acquisition timing (0-14 days) and/or (2) did not
report adjusted estimates of effect on recovery at later follow-up.
To better characterize the benefits of MRI, there is a need for
future research in the form of well-designed prospective studies
that compare the impact of MRI on patient management and
outcomes to alternate strategies (eg, no use of MRI).
Conventional MRI for Prognostication (KQ2)
Existing evidence suggests that certain MRI characteristics
are important predictors of outcomes in acute SCI, including
length of intramedullary hemorrhage and the canal diameter
at the level of MSCC. Other imaging characteristics may
also be useful for prognostication, such as alternative mea-
sures of canal stenosis, presence of hemorrhage, and longer
edema length; however, findings related to these predictors
were inconsistent. Substantial heterogeneity exists with
respect to the reporting and measurement of MRI features
and clinical outcomes and limits our ability to synthesize
findings across studies.
Prognostic studies included in this review identified that length
of intramedullary hemorrhage (moderate-quality evidence),
spinal canal diameter at the location of MSCC (low-quality evi-
dence), and baseline neurological status are important predictors
of outcome. Longer hemorrhage length was independently pre-
dictive of worse neurologic outcomes in 2 studies, particularly in
patients with complete (AISA) injuries. In addition, 3 of 5 studies
reported that the presence of hemorrhage is associatedwithworse
neurological outcomes, while 2 other studies observed an insig-
nificant association (low-quality evidence). Overall, hemorrhage
(length and presence) appears to be a predictor of worse out-
comes; however, this finding must be interpreted with caution
due to the inconsistency of results across studies. One small study
suggested that length of hemorrhage greater than 4mm is predic-
tive of poor prognosis,13 and that each millimeter increase in
hematoma length increases the risk of retaining complete impair-
ment (AIS A); these results need to be confirmed in larger pro-
spective studies with a priori hypotheses. Similarly, the finding
that decreased canal diameter at the location of MSCC is associ-
atedwithworse neurologic outcome also needs to be replicated in
a larger cohort. Two additional MRI features were inconsistently
associatedwith outcomes (MCCand greater edema lesion length)
and therefore also warrant further study. Other MRI characteris-
tics were not statistically associated with clinical outcomes; how-
ever, the level of evidence was either low or very low, suggesting
that future research may yield different results.
These prognostic studies were largely exploratory, investi-
gated numerous MRI features, and had variable definitions of
what constitutes SCI lesion, hemorrhage, edema, and swelling.
For example, several studies categorized any abnormal T2-
weighted signal as a “lesion,” whereas another study combined
edema and hemorrhage together in a single variable (edema ¼ 1
point, hemorrhage ¼ 2 points).11 Heterogeneity in imaging pro-
tocols and the use of nonstandardized techniques for geometric
measurements such as MCC, MSCC, hemorrhage length, and
edema length are also potential confounders. Moreover, none of
the included studies reported interrater reliability of these meth-
ods. Clinical outcomes varied across studies, with many studies
reporting on coarse outcomes such as AIS or Frankel grade,
rather than more sensitive measures of recovery such as Inter-
national standards for neurological classification of spinal cord
injury (ISNCSCI) motor/sensory scores and Graded Redefined
Assessment of Strength, Sensibility and Prehension
(GRASSP).16 The timing of baseline MRI also varied greatly
in the reviewed studies and ranged from hours after hospital
admission to 14 days postinjury. The magnitude of effect for
associations and corresponding confidence intervals were also
not provided in most studies. All of these factors prevented data
pooling and synthesis and the development of firm evidence-
based conclusions. Given these variations in study design, there
remain significant knowledge gaps regarding the association
between intramedullary abnormalities in the spinal cord and
neurologic, functional, patient-reported, and safety outcomes.
Overall, in interpreting the current literature, we have identified
that length of hemorrhage (moderate evidence) and decreased
canal diameter at the location of MSCC (low evidence) are
important predictors of worse neurologic outcomes.
The MRI features extracted from conventional MRI, such as
length of hemorrhage, tend to be relatively crude methods for
determining the extent of tissue compromise. Computing vol-
ume of affected tissue and identifying the location of the
pathology in the compromised spinal cord (dorsal vs ventral
grey matter and/or specific white matter columns) could further
improve prognostic performance. Conventional MRI may have
only modest prognostic utility due to its inability to distinguish
recoverable from nonrecoverable tissue injury. For example,
edema alone, whether limited or extensive, is recoverable.
On the other hand, contusion, which may have a MRI signal
indistinguishable from edema on T2-weighted images, indi-
cates a more advanced injury condition in which there is per-
manent loss of neurons. The studies included in this review did
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not utilize GRE or SWI sequences that are more sensitive for
identifying contusion and microhemorrhages. The results of
this review highlight the limitations of the traditional T1- and
T2-weighted sequences for detecting more specific patterns of
injury and quantifying reversible and irreversible components
of damage. These findings confirm the need to further develop
advanced MRI techniques that can provide a more detailed
view of injury to the spinal cord parenchyma, including DTI,
SWI, functional MRI, MR spectroscopy, perfusion imaging,
and other sequences sensitive to demyelination, such as mag-
netization transfer and myelin water fraction.17,18 However,
these advanced MRI methods will inevitably be more time
consuming and cannot yet be reliably implemented in a clinical
setting due to technical challenges; these include the need for
improved signal-to-noise ratio, high field strength (3 T or
greater), and complex data analysis that is highly labor inten-
sive. Furthermore, these advanced MRI methods would need to
be cost-effective and widely available before they are able to be
adopted clinically.
The Role of DTI in Prognostication (KQ3)
No articles were identified that assessed the predictive value of
DTI in patients with acute SCI; this constitutes an important
knowledge gap. Furthermore, there remains a lack of standar-
dization for spinal cord DTI acquisition. All of these issues
present an opportunity for future multicenter studies to evaluate
the value and practicality of DTI as a prognostic tool in acute
SCI. Since certain quantitative metrics derived from DTI
appear to correlate with important microstructural features
such as axonal integrity,17 a standardized approach to DTI that
can consistently interpret diffusion changes in the SCI zone, as
well as remotely in the spinal cord, may offer powerful pre-
dictive information following SCI.
Cost-Effectiveness of MRI in Acute SCI (KQ4)
There are no studies that evaluate the cost-effectiveness of MRI
using full economic analyses. Our search did identify one con-
ference abstract that investigated the same cohort as Papado-
poulos et al.19 This abstract by Selden et al (1999) reported that
the MRI-protocol group had a significantly shorter intensive
care unit and hospital length of stay and decreased duration of
ventilator support, resulting in an estimated savings of $50300
per case. However, details of the cost estimates were not
included, and the authors did not perform a full economic
analysis. Thus, a substantial knowledge gap exists regarding
the cost-effectiveness of MRI in the early evaluation of patients
with SCI, suggesting a strong need for further investigation.
Knowledge Gaps and Limitations
This review has identified several knowledge gaps regarding
the role of MRI in clinical decision making and outcome pre-
diction in patients with acute SCI. For each of the key questions
addressed, well-designed studies are required to clearly define
the role of MRI, the appropriate methodology of conventional
as well as advanced MRI (such as DTI), as well as the cost-
effectiveness of these strategies. This future research will help
generate clinical practice guidelines that outline the best utility
for MRI in SCI.
This systematic review has several limitations. First,
although we performed a thorough electronic literature search
in several major databases and also manually searched refer-
ence lists, it is possible that some relevant studies were missed.
We focused this review only on the highest quality studies
available that directly addressed the key questions and
restricted our inclusion criteria to those that compared MRI
versus no MRI for KQ1 and KQ4, and those that performed
multivariate analysis for KQ2 and KQ3. As a result, our review
included a small number of studies and provides only a limited
summary of the research that has occurred to date. However,
we felt justified in this approach and believe that broader inclu-
sion criteria would have resulted in the inclusion of lower level
evidence and additional heterogeneity.
Conclusions
The overall body of evidence regarding the utility of MRI in
acute SCI is limited. It has been established that MRI accu-
rately detects potentially important clinical entities such as
cord compression, disc herniation, and ligamentous injury;
however, no comparative studies were identified that link MRI
with decisions such as surgical approach and timing. Further-
more, only very low quality evidence exists linking the use of
MRI in acute SCI to clinical outcomes. It appears that MRI, in
addition to baseline neurological status, is useful for prognos-
tication; specifically, moderate-quality evidence suggests that
longer intramedullary hemorrhage and low-quality evidence
indicates that smaller spinal canal diameter at MSCC are asso-
ciated with poor neurologic recovery. No literature was iden-
tified that investigated DTI as a prognostic tool or assessed the
cost-effectiveness of MRI in acute SCI. The paucity of litera-
ture in each of these areas highlights the need for well-designed
prospective multicenter studies and full economic analyses to
better understand the utility and cost-effectiveness of MRI in
acute SCI.
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